tiprankstipranks
Pacira Pharmaceuticals Appoints Shawn Cross as CFO
Company Announcements

Pacira Pharmaceuticals Appoints Shawn Cross as CFO

Pick the best stocks and maximize your portfolio:

Pacira Pharmaceuticals ( (PCRX) ) has provided an announcement.

Pacira BioSciences has appointed Shawn Cross as its new Chief Financial Officer, bringing over 25 years of biopharmaceutical and financial expertise to the company. Previously, Cross held leadership roles at Applied Molecular Transport, including CEO, and has a strong background in investment banking. His appointment is aimed at enhancing Pacira’s financial strategies as the company continues to grow its innovative non-opioid pain therapies. Cross’s role will also include participation in the company’s incentive programs, aligning with its long-term growth objectives.

For detailed information about PCRX stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyDOMA Perpetual Capital to nominate four candidates to Pacira’s board
TheFlyPacira reports inducement grants under Nasdaq listing rule
TheFlyPacira awarded new U.S. patent covering EXPAREL composition
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App